208 results
Page 4 of 11
S-8
EX-23.1
40wpdwa9m9
9 Aug 21
Registration of securities for employees
5:28pm
S-8
v67hv9qd4h0ojd
9 Aug 21
Registration of securities for employees
5:28pm
8-K
EX-99.1
ns3du4t7ooju5elt
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
ngztm9y
25 Jun 21
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
5:26pm
8-K
leyiu35uj4o
27 May 21
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
EX-99.1
2imc3 9n80hz
10 May 21
FibroGen Reports First Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
yqtxcdv5
7 Apr 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
5l1gojsq10
6 Apr 21
Company Continues to be Confident in the Benefit / Risk Profile of Roxadustat
4:59pm
8-K
EX-99.1
r4ynt9b yp3f
1 Mar 21
FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
wz0v698
27 Jan 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
3uvg0dnug55rcihm2m
18 Dec 20
FibroGen Provides Regulatory Update on Roxadustat
5:10pm